228 related articles for article (PubMed ID: 15359288)
1. Molecular mechanisms regulating the tumor-targeting potential of splice-activated gene expression.
Hayes GM; Dougherty ST; Davis PD; Dougherty GJ
Cancer Gene Ther; 2004 Dec; 11(12):797-807. PubMed ID: 15359288
[TBL] [Abstract][Full Text] [Related]
2. Alternative splicing as a novel of means of regulating the expression of therapeutic genes.
Hayes GM; Carpenito C; Davis PD; Dougherty ST; Dirks JF; Dougherty GJ
Cancer Gene Ther; 2002 Feb; 9(2):133-41. PubMed ID: 11857030
[TBL] [Abstract][Full Text] [Related]
3. Intronic UGG repeats coordinate splicing of CD44 alternative exons v8 and v9.
Galiana-Arnoux D; Del Gatto-Konczak F; Gesnel MC; Breathnach R
Biochem Biophys Res Commun; 2005 Oct; 336(2):667-73. PubMed ID: 16137657
[TBL] [Abstract][Full Text] [Related]
4. Restricted patterns of CD44 variant exon expression in human papillary thyroid carcinoma.
Ermak G; Jennings T; Robinson L; Ross JS; Figge J
Cancer Res; 1996 Mar; 56(5):1037-42. PubMed ID: 8640758
[TBL] [Abstract][Full Text] [Related]
5. Differential expression of the hyaluronan receptors CD44 and RHAMM in human pancreatic cancer cells.
Abetamann V; Kern HF; Elsässer HP
Clin Cancer Res; 1996 Sep; 2(9):1607-18. PubMed ID: 9816340
[TBL] [Abstract][Full Text] [Related]
6. Alternatively spliced CD44 isoforms containing exon v10 promote cellular adhesion through the recognition of chondroitin sulfate-modified CD44.
Chiu RK; Droll A; Dougherty ST; Carpenito C; Cooper DL; Dougherty GJ
Exp Cell Res; 1999 Apr; 248(1):314-21. PubMed ID: 10094837
[TBL] [Abstract][Full Text] [Related]
7. The influence of hormones on CD44 expression in endometrial and breast carcinomas.
Durst B; Sorg RV; Röder G; Betz B; Beckmann MW; Niederacher D; Bender HG; Dall P
Oncol Rep; 2001; 8(5):987-93. PubMed ID: 11496303
[TBL] [Abstract][Full Text] [Related]
8. Identification of novel splice variants of the human CD44 gene.
Vela E; Roca X; Isamat M
Biochem Biophys Res Commun; 2006 Apr; 343(1):167-70. PubMed ID: 16530165
[TBL] [Abstract][Full Text] [Related]
9. Alternative splicing of CD44 pre-mRNA in human colorectal tumors.
Finn L; Dougherty G; Finley G; Meisler A; Becich M; Cooper DL
Biochem Biophys Res Commun; 1994 Apr; 200(2):1015-22. PubMed ID: 7513991
[TBL] [Abstract][Full Text] [Related]
10. Expression and alternative splicing of the deleted in colorectal cancer (DCC) gene in normal and malignant tissues.
Reale MA; Hu G; Zafar AI; Getzenberg RH; Levine SM; Fearon ER
Cancer Res; 1994 Aug; 54(16):4493-501. PubMed ID: 8044801
[TBL] [Abstract][Full Text] [Related]
11. Transcription and expression of CD44 variant exons by oro-pharyngeal squamous cell carcinomas.
Bloor BK; Rajarajan A; Jaafary-Haghighat K; Odell EW
Int J Oncol; 2002 Oct; 21(4):907-13. PubMed ID: 12239634
[TBL] [Abstract][Full Text] [Related]
12. Extracellular matrix gene alternative splicing by trabecular meshwork cells in response to mechanical stretching.
Keller KE; Kelley MJ; Acott TS
Invest Ophthalmol Vis Sci; 2007 Mar; 48(3):1164-72. PubMed ID: 17325160
[TBL] [Abstract][Full Text] [Related]
13. Alternative splicing of c-fos pre-mRNA: contribution of the rates of synthesis and degradation to the copy number of each transcript isoform and detection of a truncated c-Fos immunoreactive species.
Jurado J; Fuentes-Almagro CA; Prieto-Alamo MJ; Pueyo C
BMC Mol Biol; 2007 Sep; 8():83. PubMed ID: 17888145
[TBL] [Abstract][Full Text] [Related]
14. Expression of CD44 isoforms in renal cell tumors. Positive correlation to tumor differentiation.
Terpe HJ; Störkel S; Zimmer U; Anquez V; Fischer C; Pantel K; Günthert U
Am J Pathol; 1996 Feb; 148(2):453-63. PubMed ID: 8579108
[TBL] [Abstract][Full Text] [Related]
15. Deregulated alternative splicing of CD44 messenger RNA transcripts in neoplastic and nonneoplastic lesions of the human thyroid.
Ermak G; Gerasimov G; Troshina K; Jennings T; Robinson L; Ross JS; Figge J
Cancer Res; 1995 Oct; 55(20):4594-8. PubMed ID: 7553635
[TBL] [Abstract][Full Text] [Related]
16. A single base mutation in the 5' splice site of intron 7 of the lck gene is responsible for the deletion of exon 7 in lck mRNA of the JCaM1 cell line.
Rouer E; Brule F; Benarous R
Oncogene; 1999 Jul; 18(29):4262-8. PubMed ID: 10435639
[TBL] [Abstract][Full Text] [Related]
17. Identification of three mouse mu-opioid receptor (MOR) gene (Oprm1) splice variants containing a newly identified alternatively spliced exon.
Doyle GA; Rebecca Sheng X; Lin SS; Press DM; Grice DE; Buono RJ; Ferraro TN; Berrettini WH
Gene; 2007 Feb; 388(1-2):135-47. PubMed ID: 17156941
[TBL] [Abstract][Full Text] [Related]
18. Molecular structure and alternative splicing of the human carboxypeptidase M gene.
Pessoa LG; da Silva ID; Baptista HA; Pesquero JL; Paiva AC; Bader M; Pesquero JB
Biol Chem; 2002 Feb; 383(2):263-9. PubMed ID: 11934264
[TBL] [Abstract][Full Text] [Related]
19. Exon skipping of midkine pre-mRNA is enhanced by intronic polymorphism in a colon cancer cell line.
Nobata S; Mogi H; Shinozawa T
Cancer Lett; 2004 Apr; 207(1):89-93. PubMed ID: 15050737
[TBL] [Abstract][Full Text] [Related]
20. Acidic stimulation induces a negative regulatory factor that affects alternative exon selection in vitro in human ATP synthase gamma-subunit pre-mRNA.
Hayakawa M; Endo H; Hamamoto T; Kagawa Y
Biochem Biophys Res Commun; 1998 Oct; 251(2):603-8. PubMed ID: 9792820
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
